Agents affecting porphyrin formation and secretion: implications for porphyria cutanea treatment.
作者信息
Kordac V, Jirsa M, Kotal P, Kaláb M, Cervinka J, Kotyk A, Martásek P
机构信息
First Department of Medicine, Charles University, Prague, Czechoslovakia.
出版信息
Semin Hematol. 1989 Jan;26(1):16-23.
PMID:2646720
Abstract
摘要
相似文献
1
Agents affecting porphyrin formation and secretion: implications for porphyria cutanea treatment.影响卟啉形成和分泌的因素：对迟发性皮肤卟啉症治疗的意义
Semin Hematol. 1989 Jan;26(1):16-23.
2
Follow-up studies of porphyrin excretion in porphyria cutanea tarda treated with p-aminobenzoic acid.
Ann Clin Res. 1980 Dec;12(6):279-81.
3
Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.促红细胞生成素治疗血液透析相关迟发性皮肤卟啉病。
Nephrol Dial Transplant. 1992;7(5):438-42.
4
[Treatment of porphyria cutanea tarda with intermittent chloroquine].
Hautarzt. 1980 Aug;31(8):437-40.
5
[Disorder of porphyrin metabolism in late porphyria cutanea tarda].迟发性皮肤卟啉病中的卟啉代谢紊乱
Vrach Delo. 1968 Jul;7:141-2.
6
[Fecal porphyrin analyses in patients with porphyria cutanea tarda].
Nihon Hifuka Gakkai Zasshi. 1987 Feb;97(2):151-6.
7
Biochemical study of fecal porphyrin in porphyria cutanea tarda.
J Dermatol. 1987 Aug;14(4):291-6. doi: 10.1111/j.1346-8138.1987.tb03581.x.
8
[Porphyrin metabolic disorders in porphyria cutanea tarda].
Vestn Dermatol Venerol. 1989(8):67-71.
9
Porphyria cutanea tarda.迟发性皮肤卟啉病
Int J Dermatol. 1979 Dec;18(10):767-80. doi: 10.1111/j.1365-4362.1979.tb04463.x.
10
The cutaneous porphyrias.皮肤型卟啉病
Dermatol Clin. 2014 Jul;32(3):369-84, ix. doi: 10.1016/j.det.2014.03.001. Epub 2014 May 5.
引用本文的文献
1
Diagnosis and management of porphyria.卟啉病的诊断与管理
BMJ. 2000 Jun 17;320(7250):1647-51. doi: 10.1136/bmj.320.7250.1647.
Zotero 插件